NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2021
October 29, 2021 at 04:27 am
NanJing Pharmaceutical Company Limited reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 33,396.83 million compared to CNY 29,073.88 million a year ago. Net income was CNY 346.33 million compared to CNY 282.68 million a year ago. Basic earnings per share from continuing operations was CNY 0.33 compared to CNY 0.27 a year ago. Diluted earnings per share from continuing operations was CNY 0.33 compared to CNY 0.27 a year ago.